Skip to main content
NPJ Schizophrenia logoLink to NPJ Schizophrenia
. 2015 Nov 18;1:15049. doi: 10.1038/npjschz.2015.49

Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study

Marco Colizzi, Conrad Iyegbe, John Powell, Giuseppe Blasi, Alessandro Bertolino, Robin M Murray, Marta Di Forti
PMCID: PMC4849466  PMID: 27336809

Correction to: npj Schizophrenia (2015) 1, Article number: 15025. doi:10.1038/npjschz.2015.25

In the published version of this article, in Table 1, under the entry ‘Cannabis use’, some N (%) data were incorrect due to a minor miscalculation. The corrected table appears below. The authors regret the error.

Table 1. Demographic measures and patterns of drug use in FEP patients and control subjects.

PZ
Controls
N % N %
Cannabis use
 Yes 158 71.2 142 62.3
  No risk allele 34 21.5 40 28.2
  One risk allele 89 56.3 82 57.7
  Two risk alleles 35 22.2 20 14.1
 Never 64 28.8 86 37.7
  No risk allele 20 31.2 17 19.8
  One risk allele 35 54.7 51 59.3
  Two risk alleles 9 14.1 18 20.9
       
Frequency of use
 Daily 92 63.9 43 39.8
  No risk allele 19 20.7 12 27.9
  One risk allele 51 55.4 22 51.2
  Two risk alleles 22 23.9 9 20.9
 Weekly or less 52 36.1 65 60.2
  No risk allele 12 23.1 20 30.8
  One risk allele 29 55.7 37 56.9
  Two risk alleles 11 21.2 8 12.3
       
No details 14 34

Articles from NPJ Schizophrenia are provided here courtesy of Nature Publishing Group

RESOURCES